1.64
-0.54 (-24.77%)
-0.54 (-24.77%)
Upgrade to Real-Time
Afterhours (Closed)
Best deals to access real time data! |
|
Big Cap Pro
Monthly Subscription
for only
|
|
Real-Time Alerts for Volume Breakouts, Highs and Lows for NYSE, NASDAQ, Amex, OTC Markets and OTCBB
Monthly Subscription
for only
|
|
Level 1 Starter
Monthly Subscription
for only
|
|
VAT not included
|
| Company Name | Stock Ticker Symbol | Market | Type |
|---|---|---|---|
| Hepion Pharmaceuticals Inc | HEPA | NASDAQ | Common Stock |
| Price Change | Change Percent | Stock Price | Last Traded  |
|
|---|---|---|---|---|
| -0.54 | -24.77% | 1.64 | 19:59:50 |
| Open Price | Low Price | High Price | Close Price | Previous Close |
|---|---|---|---|---|
| 1.58 | 1.51 | 1.65 | 1.58 | 2.18 |
| Bid Price | Ask Price | Spread | News | |
|---|---|---|---|---|
| 1.62 | 1.63 | 0.01 | 2 | - |
| Stock Trades | Traded Volume | VWAP | Dollar Volume | Average Volume | 52 Week Range |
|---|---|---|---|---|---|
| 32,667 | 10,501,481 | $ 1.59 | $ 16,660,358 | 518,757 | 1.00 - 8.35 |
| Last Trade Time | Type | Quantity | Stock Price | Currency |
|---|---|---|---|---|
| 19:59:19 | formt | 500 | $ 1.64 | USD |
Hepion Pharmaceuticals Financials
| Market Cap | Shares in Issue | Float | Revenue | Profit/Loss | EPS | PE Ratio |
|---|---|---|---|---|---|---|
| $ 14.80M | 9.03M | 9.02M | $ - | $ - | -15.29 | -1.60 |
| Short Interest | Dividends Per Share | Dividend Yield | Ex-Div Date | Insider B/S | Insider % Owned |
|---|---|---|---|---|---|
| - | $ - | 0.00% | - | 10.50% |
Hepion Pharmaceuticals News
Loading Messages....
|
|
{{bbMessage.M_Alias}} {{bbMessage.MSG_Date}} {{bbMessage.HowLongAgo}} {{bbMessage.MSG_ID}} {{bbMessage.MSG_Subject}} |
Loading Messages....
Historical HEPA Price Data
| Period † | Open | High | Low | VWAP | Avg. Daily Vol | Change | % |
|---|---|---|---|---|---|---|---|
| 1 Week | 2.72 | 2.82 | 1.51 | 2.38 | 415,025 | -1.08 | -39.71% |
| 1 Month | 3.38 | 3.4226 | 1.51 | 2.61 | 208,776 | -1.74 | -51.48% |
| 3 Months | 3.07 | 4.24 | 1.51 | 3.03 | 185,510 | -1.43 | -46.58% |
| 6 Months | 2.04 | 6.18 | 1.51 | 3.75 | 914,162 | -0.40 | -19.61% |
| 1 Year | 3.57 | 8.35 | 1.00 | 3.94 | 893,135 | -1.93 | -54.06% |
| 3 Years | 3.11 | 8.35 | 1.00 | 3.79 | 904,599 | -1.47 | -47.27% |
| 5 Years | 3.11 | 8.35 | 1.00 | 3.79 | 904,599 | -1.47 | -47.27% |
Hepion Pharmaceuticals Description
| Hepion Pharmaceuticals Inc is a United States-based biopharmaceutical company engaged in the development of targeted pharmaceutical therapies for liver disease. This therapeutic approach targets fibrosis and hepatocellular carcinoma associated with non-alcoholic steatohepatitis, viral hepatitis, and other liver diseases. The company's cyclophilin inhibitor, CRV431 targets multiple biochemical pathways involved in the progression of liver disease. |
